The DOI matches its Crossref record; 154 of the 156 references it cites were found in a registry or an index.
Role of computer-aided drug design in modern drug discovery
Abstract
Drug discovery utilizes chemical biology and computational drug design approaches for the efficient identification and optimization of lead compounds. Chemical biology is mostly involved in the elucidation of the biological function of a target and the mechanism of action of a chemical modulator. On the other hand, computer-aided drug design makes use of the structural knowledge of either the target (structure-based) or known ligands with bioactivity (ligand-based) to facilitate the determination of promising candidate drugs. Various virtual screening techniques are now being used by both pharmaceutical companies and academic research groups to reduce the cost and time required for the discovery of a potent drug. Despite the rapid advances in these methods, continuous improvements are critical for future drug discovery tools. Advantages presented by structure-based and ligand-based drug design suggest that their complementary use, as well as their integration with experimental routines, has a powerful impact on rational drug design. In this article, we give an overview of the current computational drug design and their application in integrated rational drug development to aid in the progress of drug discovery research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Computer-aided drug design has helped expedite the development of small-molecule inhibitors.172,173”
From Chasing molecular glue degraders: screening approaches (2022) · cites this paper as [172]
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 26,294
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Scalable molecular dynamics with NAMD
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20289 · Cited by 16,914
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M., Smith, J., Kasson, P., van der Spoel, D., et al. (2013) · Bioinform. · doi:10.1093/bioinformatics/btt055 · Cited by 7,255
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 4,196
Cramer, R. D., Patterson, D. E., & Bunce, J. D. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00226a005 · Cited by 3,931
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Cited by
Sorted by citations
Items 601–700 of 763
Advances in the Application of Biological Big Data in Medicine
Luo, Z. (2022) · Academic Journal of Medicine & Health Sciences · doi:10.25236/ajmhs.2022.030204
Dabral, S., Khan, I. A., Pant, T., Khan, S. Q., Prakash, P., Parvez, S., & Saha, N. (2023) · ACS Omega · doi:10.1021/acsomega.2c07570 · Cited by 1
S, B. G. A., Madaj, R., Valluri, P. P., & Sanker, A. (2021) · doi:10.31219/osf.io/b8y79 · Cited by 1
Singh, M., Kongsted, J., Zhan, P., Banerjee, U. C., Poongavanam, V., & Murugan, N. A. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-bnxq5 · Cited by 1
zPoseScore model for accurate and robust protein-ligand docking pose scoring in CASP15Preprint
Zheng, L., Shen, T., Liu, F., Wang, Z., Sun, J., Bu, Y., Meng, J., Chen, W., Mu, Y., Li, W., et al. (2023) · doi:10.22541/au.168170991.15467381/v1 · Cited by 1
Potey, L., Waghmare, S., Dudhe, A. R., Dudhe, R., & Sabale, P. (2024) · doi:10.1002/9781394159338.ch13 · Cited by 1
Natural Products-inspired Drug Discovery Using Computer-aided Drug Design Techniques
Upadhyay, H. C. (2026) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266499782260427045530 · Cited by 1
Borges, F., Cruz‐Monteagudo, M., Helguera, A. M., Pérez‐Castillo, Y., Cordeiro, M. N. D. S., Tejera, E., Paz‐y‐Miño, C., Sánchez‐Rodríguez, A., Teijeira-Bautista, M., Ancede‐Gallardo, E., et al. (2015) · MOL2NET International Conference on Multidisciplinary Sciences (MOL2NET) · doi:10.3390/mol2net-1-b033
Pérez‐Castillo, Y., Helguera, A. M., Cordeiro, M. N. D. S., Tejera, E., Paz‐y‐Miño, C., Sánchez‐Rodríguez, A., Borges, F., & Cruz‐Monteagudo, M. (2015) · MOL2NET International Conference on Multidisciplinary Sciences (MOL2NET) · doi:10.3390/mol2net-1-b031
Computational modelling of ligand shape and interactions for medicines design
Jaiyong, P. (2016) · Research Explorer (The University of Manchester)
(2017) · International Journal of Current Research and Review · doi:10.7324/ijcrr.2017.9194
Binding Affinity Regression Models from Repeats Mutation in Polyglutamine DiseasePreprint
Asha, P. R., & Vijaya, M. S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/281949
Modeling of Cell Membrane Systems
Ildeniz, T. A. Ö. (2019) · Springer eBooks · doi:10.1007/978-3-030-11596-8_4
González, P., & González, E. A. P. (2020)
Correa, M., & Solorzano, S. (2020) · Minerva · doi:10.47460/minerva.v1i1.2
Madaj, R., S, B. G. A., Sanker, A., & Valluri, P. P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.11.421768
Etman, A. G., Abostate, H. M., El-damasy, D. A., Soliman, D. H., & Radwan, S. (2021) · Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences · doi:10.21608/aijpms.2021.52437.1008
Fragment based drug design: Connecting small substructures for a bioactive lead
Silakari, O., & Singh, P. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820546-4.00010-6
Anticancer Lead Compounds that Prevent DNA Binding to hnRNP K
da Silva, V. B., Silva, F. A. M. E., Garcia, C. B., Leopoldino, A. M., da Silva, C. H. T. D. P., & Taft, C. A. (2021) · Engineering materials · doi:10.1007/978-3-030-62226-8_23
Kumar, S., Kumar, N., Sharma, C. S., & Mishra, S. S. (2021) · Europe PMC (PubMed Central) · doi:10.22037/ijpr.2020.113746.14464
Swamy, C. T. (2021) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.15.3.52
Molecular Pharmacological Tools Applied to Epidemiology
Barrera-Vázquez, O. S., Flores‐Soto, E., & Gómez-Verján, J. C. (2022) · Springer eBooks · doi:10.1007/978-3-030-89601-0_15
Computer-Aided Drug Design Boon in Drug Discovery
Sharma, A., Jangid, L., Shaikh, N. K., & Bhangale, J. O. (2022) · Asian Journal of Organic & Medicinal Chemistry · doi:10.14233/ajomc.2022.ajomc-p361
Busca de pequenas moléculas naturais inibidoras da Rab10 para o tratamento da doença de Alzheimer
Alves, L. B. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-08082022-110212
Descubrimiento de nuevos anticonvulsivos que actúan mediante interacciones con canales iónicos
Llanos, M. A. (2022) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/140503
Algorithm Selection for Protein-Ligand Docking: A Case Study on ACE with AutoDockPreprint
Chen, T., Zhou, H., Shu, X., Beckford, F. A., & Mısır, M. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-19xh6
Introductory Chapter: Drug Development Life Cycle
Akhtar, J., & Badruddeen, B. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106480
Decision: Computational drug discovery under RNA times — R1/PR4
Bernetti, M., Aguti, R., Bosio, S., et al. (2022) · QRB Discovery · doi:10.1017/qrd.2022.20.pr4
Decision: Computational drug discovery under RNA times — R2/PR5
Bernetti, M., Aguti, R., Bosio, S., et al. (2022) · QRB Discovery · doi:10.1017/qrd.2022.20.pr5
Decision: Computational drug discovery under RNA times — R0/PR3
Bernetti, M., Aguti, R., Bosio, S., et al. (2022) · QRB Discovery · doi:10.1017/qrd.2022.20.pr3
Review: Computational drug discovery under RNA times — R0/PR1
Bernetti, M., Aguti, R., Bosio, S., et al. (2022) · QRB Discovery · doi:10.1017/qrd.2022.20.pr1
Pasrija, R. (2022) · Springer eBooks · doi:10.1007/978-981-19-6506-7_1
Review: Computational drug discovery under RNA times — R0/PR2
Bernetti, M., Aguti, R., Bosio, S., et al. (2022) · QRB Discovery · doi:10.1017/qrd.2022.20.pr2
Mechanisms of Semen Cassiae to Treat Hypercholesterolemia Based on Molecular Docking
Ye, Q. (2022) · Journal of Innovations in Medical Research · doi:10.56397/jimr/2022.12.06
ChemTSv2: Democratizing Functional Molecular Design Using de novo Molecule GeneratorPreprint
Ishida, S., Aasawat, T. K., Sumita, M., Katouda, M., Yoshizawa, T., Yoshizoe, K., Tsuda, K., & Terayama, K. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-mb880
Yousaf, M., Fatima, D., Amin, J., Noureen, A., & Fatmi, M. Q. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2174188
Biomolecular Network-based Study of a Parasitic Disease and Therapeutic Drugs
Avirmed, A., Erdenedalai, U., Erdenechimeg, S., Su, Y., & Ishdorj, T.-O. (2022) · ICT Focus · doi:10.58873/sict.v1i1.31
PARASHAR, P., & Sharma, S. (2023) · Innovare Journal of Medical Sciences · doi:10.22159/ijms.2023.v11i2.47146
Targeting Toxoplasma gondii ME49 TgAPN2: A Bioinformatics Approach for Antiparasitic Drug Discovery
Altharawi, A. (2023) · Molecules · doi:10.3390/molecules28073186
Geometric and topological AI for molecular sciences
Wee, J. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/165903
In silico -based identification of new anti-pfdhfr drug candidates via 1,3,5-triazine derivatives
Khelfa, N., Belaıdı, S., Zerroug, E., Soualmia, F., & Chtita, S. (2023) · Main Group Chemistry · doi:10.3233/mgc-220111
Advanced Applications of Computer Aided Drug Design in Pharmaceutical Sciences
Punia, S., Yadav, R., Upadhayay, P., Kapoor, A., Kumar, A., & Misra, S. K. (2023) · Acta Scientific Pharmaceutical Sciences · doi:10.31080/asps.2023.07.0956
Process of Drug designing in modern times: An analytical study
Khan, A. N. (2018) · doi:10.52783/nveo.5464
Xu, T., Luo, L., & Chen, C. (2023) · International Conference on Artificial Intelligence, Automation and High Performance Computing (AIAHPC) · doi:10.1117/12.2687020
Alrumaihi, F. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2233618
Facilitating the drug repurposing with iC/E strategy: A practice on novel nNOS inhibitor discovery
Hu, Z., Liu, Q., & Zhong, N. (2023) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s021972002350018x
Pharmacophore-based Virtual Screening: Identification of Selective Sirtuin 2 Inhibitors
Karaman, B., & Alayoubi, M. M. (2023) · Journal of Research in Pharmacy · doi:10.29228/jrp.424
In vitro Antibacterial Activity of Dye Compounds
Hoepfner, A., Bezuidenhout, J. J., Petzer, A., Petzer, J. P., & Cloete, T. T. (2023) · Letters in Drug Design & Discovery · doi:10.2174/1570180820666230725110021
Enrichment of virtual screening results using induced-fit techniques
Fernández, J. M. I. (2020) · doi:10.5821/dissertation-2117-180787
Cheminformatics-driven Discovery of Hit Compounds Against Paracoccidioides spp.
de Oliveira, A. A., Silva, L. D. C., Neves, B. J., Costa, V. A. F., Muratov, E. N., Andrade, C. H., Soares, C. M. D. A., Alves, V. M., & Pereira, M. (2023) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0288
Drugs and Therapeutic Targets in Breast Cancer: Physicochemical Analysis by Computational Chemistry
Stockton, A. M., Aguiñaga-Miramontes, A. K., Saenzpardo, R. P., Jurado, R. Q., García, R., Camarillo‐Cisneros, J., & Márquez-Barreto, A. C. (2023) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-031-46933-6_16
Anticancer Activity of Medicinal Plants Extract and Molecular Docking Studies
Çetinkaya, S., & Tüzün, B. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815179934123010007
Bilgisayar Destekli İlaç Tasarımı ve Tasarımın Ticari Ürün Örneklerine Kısa Bir Bakış
Karabulut, Y. K., & TURHAN, Z. Ş. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1553
Yeşil Sentez: Nano Partiküller ve Potansiyel Uygulama Alanları
Yiğit, A., Karakoyun, N., & TURHAN, Z. Ş. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1554
Nanotechnology and Current Applications in Biotechnology
Bozbeyoğlu, P., & Keçeci, P. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1559
Astım ve Lökotrien Reseptör Antagonistleri
Dilek, G. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1561
Nanoteknoloji ve Organik Kimya
Demirci, M. A. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1558
Nanoteknoloji ve Organik Kimya
Yiğit, A., Karabulut, Y. K., Turhan, Z., Yiğit, A., Karakoyun, N., Yıldız, G., Kasımoğulları, R., Biçer, A., Demirel, N., Demirci, M. A., et al. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393
Biyoaktif Bileşiklerin Elektrospinning Yöntemi İle Nanoenkapsülasyonu
Çeliközlü, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1560 · Cited by 1
Nanobiyoteknoloji ile Sürdürülebilir Bitki Sağlığı ve Çevre Yönetimi
Demirel, N. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1557
Recent Developments in Benzimidazole Derivatives (2023)
Yıldız, G., & Kasımoğulları, R. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1555
β-Sülfonil Ketonların Sentez Yöntemleri
Biçer, A. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub393.c1556
Exploring avenues for Alzheimer’s drugs: current status and future outlook
Rathi, K. M., Wavhale, R. D., V., V. U., Bhole, R. P., & Dherange, S. D. (2024) · Russian neurological Journal · doi:10.30629/2658-7947-2023-28-6-19-33
Computational analysis in epithelial tissue regeneration
Chhabra, P., & Gandhi, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13222-3.00024-1
Synthesis of eugenol esters derivatives as breast cancer drugs
Pangesti, D. P., Az-Zahra, N. F., Warsito, W., & Masruri, M. (2024) · AIP conference proceedings · doi:10.1063/5.0194082 · Cited by 1
Additional file 5 of Peptide aptamer-based time-resolved fluoroimmunoassay for CHIKV diagnosis
Liu, T., Cheng, G., Wang, J., Song, J., Chen, X., Chen, H., Zhao, X., Tang, H., & Gu, D. (2023) · Figshare · doi:10.6084/m9.figshare.23797412
Additional file 6 of Peptide aptamer-based time-resolved fluoroimmunoassay for CHIKV diagnosis
Liu, T., Cheng, G., Wang, J., Song, J., Chen, X., Chen, H., Zhao, X., Tang, H., & Gu, D. (2023) · Figshare · doi:10.6084/m9.figshare.23797415
Mahmood, U., Iftikhar, S., Zahra, N. U. A., & Uddin, R. (2024) · Chemical Papers · doi:10.1007/s11696-024-03416-3
Lorenc, A., Badura, A., Karolak, M., Pałkowski, Ł., Kubik, Ł., & Buciński, A. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03699-x
Rodríguez, S. (2024) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/165420
Osemwegie, O. O., Acho, M. A., Nwonuma, C. O., Udoh, R. I., & Adefarati, E. T. (2024) · International Conference on Science, Engineering and Business for Driving Sustainable Development Goals (SEB4SDG) · doi:10.1109/seb4sdg60871.2024.10630088
Hfaiedh, A., Dammak, M. I., Brahim, M., Smari, I., Mabrouk, N. B., Majdoub, H., & Ammar, H. B. (2024) · Chemistry Africa · doi:10.1007/s42250-024-01054-6
Macêdo, R. D. M., ALENCAR, W., da Costa, K. S., & GODOY, R. (2024) · Revista Brasileira de Criminalística · doi:10.15260/rbc.v13i3.856
Anand, S. R., Kumar, K., Bairwa, D., Meena, R. P., Bagoria, R., Sharma, S., Yadav, S. P., & Kumar, A. (2024) · Qeios · doi:10.32388/ysln1h
Bioinformatic importance in drug designing
Bahrami, S., & Saadatian, Z. (2023) · Taḥqīq va tusi̒ah-i salāmata · doi:10.61186/jhrd.1.2.60
Deng, B., Hua, Y., Zhang, W., Song, X., & Wu, X. (2024) · Lecture notes in computer science · doi:10.1007/978-3-031-78198-8_14
A Review of Drug-Target Interaction Prediction Methods
Yu, J., Wang, Y., & Lou, J. (2025) · Communications in computer and information science · doi:10.1007/978-981-96-3752-2_11
Gyebi, G. A., & Sabiu, S. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108458
Ghosh, B., Ava, F. K., Ferdoushi, A., Al‐Juboori, A. A. A., Karim, M. F., & Rahman, M. M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5245388
Algorithm Selection for Protein Structure Prediction on 2D AB Off-lattice Model
Mısır, M. (2024) · International Conference on Computational Biology and Bioinformatics (ICCBB) · doi:10.1145/3715020.3715049
Haydar, G., Altaf, A. A., Iqbal, A., Hashmat, U., & Kausar, S. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500157
QSAR Studies on HIV-1 Protease—A Battle against HIV Using Computational Chemistry
Sanjana, P. S. K., Vangala, R., & Sivan, S. K. (2025) · Computational Chemistry · doi:10.4236/cc.2025.131001
Data‐Driven Ranking and Selection With Simultaneous Input Data Collection and Simulation
Wang, Y., & Zhou, E. (2025) · Naval Research Logistics (NRL) · doi:10.1002/nav.22275
Bhor, R. J., Gaikwad, M. S., Anap, H. N., Vikhe, V. P., Dighe, M. R., Kashid, H. M., Jondhale, N. M., Mulay, S. U., Gaikwad, U., & Jadhav, S. E. (2025) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3388
From Ai Modeling to Validation: A 10-Day Pipeline for Potential Lead Compounds ValidationPreprint
Shao, W., Chen, B., Hu, Y., He, W., Li, G., Liu, R., Li, J., Li, X., Wei, L., Gu, A., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5375676
Structure-Based Computer-Aided Drug Design
Singhal, S., & Rani, V. (2025) · Advances in Science, Technology & Innovation/Advances in science, technology & innovation · doi:10.1007/978-3-031-80973-6_11
Predictive Models for Drug Development Using Expert Systems
Joshi, N., Joshi, D. C., Koranga, S., Gurow, K., & Chavan, M. B. (2025) · Wiley eBooks · doi:10.1002/9781394287383.ch5
A systems approach to B-cell development identifies BDNF as a regulator of human B lymphopoiesisPreprint
Nevo, N., Klein, Y., Alpert, A., Grau, A., Melamed, D., Few-Cooper, T. J., Milman, N., & Shen-Orr, S. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.29.673055
Metwaly, A. M., Abd-El-Azim, H., Zewail, M., Alsfouk, A. A., Elkaeed, E. B., Elkady, H., & Eissa, I. H. (2025) · Natural Product Communications · doi:10.1177/1934578x251384515
Metadata
- Authors
- Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S.
- Affiliations
- Ewha Womans University (KR)
- Corresponding author
- Choi, Sun
- Venue
- Archives of Pharmacal Research
- Published
- 2015-07-25
- Volume
- 38
- Issue
- 9
- Pages
- 1686-1701
- ISSN
- 0253-6269 (ISSN-L)
- 1976-3786
- OpenAlex
- W1854810044
- Cited by
- 762
- References
- 156
- Citations by year
- 2026: 65 · 2025: 80 · 2024: 109 · 2023: 146 · 2022: 105 · 2021: 96 · 2020: 60 · 2019: 41 · 2018: 31 · 2017: 15 · 2016: 10 · 2015: 2
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Archives of Pharmacal Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- The Ministry of Science, ICT & Future Planning (MSIP) and National Research Foundation of Korea (2011-0028885)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Keywords
- computer-aided drug design, drug discovery, structure-based drug design, ligand-based drug design, virtual screening, chemical biology, lead optimization, rational drug design
- MeSH terms
- Animals, Pharmaceutical Preparations, Humans, Drug Design, Computer-Aided Design, Protein Structure, Secondary, Protein Structure, Tertiary, Quantitative Structure-Activity Relationship, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review